carbamates has been researched along with Hallucinations in 6 studies
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this analysis of the effects of cholinergic therapy in dementia with Lewy bodies was to determine whether rivastigmine-induced benefits in attention and memory could be predicted by the presence of visual hallucinations." | 9.11 | Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. ( Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA, 2004) |
"The observation that patients with Parkinson's disease dementia have extensive cholinergic deficits led to the hypothesis that cholinesterase inhibitors may provide benefits for patients with this condition." | 5.31 | Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. ( Bullock, R; Cameron, A, 2002) |
"The aim of this analysis of the effects of cholinergic therapy in dementia with Lewy bodies was to determine whether rivastigmine-induced benefits in attention and memory could be predicted by the presence of visual hallucinations." | 5.11 | Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. ( Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA, 2004) |
"Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits." | 1.32 | A case study in the treatment of dementia with Lewy bodies. ( Kaufer, DI, 2004) |
"The observation that patients with Parkinson's disease dementia have extensive cholinergic deficits led to the hypothesis that cholinesterase inhibitors may provide benefits for patients with this condition." | 1.31 | Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. ( Bullock, R; Cameron, A, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujishiro, H | 1 |
Bullock, R | 1 |
Cameron, A | 1 |
Wobrock, T | 1 |
Retz-Junginger, P | 1 |
Retz, W | 1 |
Supprian, T | 1 |
Rösler, M | 1 |
McKeith, IG | 2 |
Wesnes, KA | 1 |
Perry, E | 1 |
Ferrara, R | 1 |
Kaufer, DI | 1 |
Reading, PJ | 1 |
Luce, AK | 1 |
2 trials available for carbamates and Hallucinations
Article | Year |
---|---|
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Topics: Aged; Attention; Carbamates; Disease Progression; Double-Blind Method; Female; Hallucinations; Human | 2004 |
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial.
Topics: Aged; Carbamates; Caregivers; Cognition Disorders; Female; Follow-Up Studies; Hallucinations; Humans | 2001 |
4 other studies available for carbamates and Hallucinations
Article | Year |
---|---|
Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies.
Topics: Aged; Carbamates; Dopamine Agonists; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Japan; | 2014 |
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Dementia; Female; Hallucinations; Humans; Male; Parkins | 2002 |
[Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
Topics: Affective Disorders, Psychotic; Aged; Aged, 80 and over; Alzheimer Disease; Anxiety Disorders; Carba | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galant | 2004 |